Skip to main content
. Author manuscript; available in PMC: 2012 Apr 15.
Published in final edited form as: Cancer. 2010 Nov 8;117(8):1736–1744. doi: 10.1002/cncr.25744

Table 2.

Pamidronate experience in pediatrics

Year Indication Age Range Dose Schedule Reference
1997 Hypercalcemia 4 [37]
1998 Hypercalcemia 2 – 15 1 mg/kg [39]
2001 Hypercalcemia 5 1 mg/kg [38]
2000 Fibrous dysplasia 0.5–1 mg/kg
qd ×3 days
q6months [40]
2001 Langerhans cell histiocytosis 14 2 mg/kg
qd × 3 days
q1month [63]
2002 Osteogenesis imperfecta 1 – 16 0.25–1 mg/kg
qd × 3 days
q2-4months [41]
2001 ALL 3 – 16 1 mg/kg
qd × 3 days
q3months [44]